Cite
Li L, Liu S, Liu L, et al. Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy. Exp Ther Med. 2018;16(4):2949-2959doi: 10.3892/etm.2018.6584.
Li, L., Liu, S., Liu, L., Ma, Z., Feng, M., Ye, C., Zhou, W., Wang, Y., Liu, L., Wang, F., Yu, L., Zhou, F., Xiang, Y., Huang, S., Fu, Q., Zhang, Q., Gao, D., & Yu, Z. (2018). Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy. Experimental and therapeutic medicine, 16(4), 2949-2959. https://doi.org/10.3892/etm.2018.6584
Li, Liang, et al. "Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy." Experimental and therapeutic medicine vol. 16,4 (2018): 2949-2959. doi: https://doi.org/10.3892/etm.2018.6584
Li L, Liu S, Liu L, Ma Z, Feng M, Ye C, Zhou W, Wang Y, Liu L, Wang F, Yu L, Zhou F, Xiang Y, Huang S, Fu Q, Zhang Q, Gao D, Yu Z. Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy. Exp Ther Med. 2018 Oct;16(4):2949-2959. doi: 10.3892/etm.2018.6584. Epub 2018 Aug 07. PMID: 30233667; PMCID: PMC6143873.
Copy
Download .nbib